메뉴 건너뛰기




Volumn 17, Issue 3, 2011, Pages 199-205

Dimebolin in Dementia

Author keywords

Alzheimer's disease; Dementia; Dimebolin; Dimebon; Memory

Indexed keywords

DIMEBON; DONEPEZIL; MEMANTINE; PLACEBO;

EID: 79955730441     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00156.x     Document Type: Review
Times cited : (13)

References (36)
  • 1
    • 38449116472 scopus 로고    scopus 로고
    • Dimebolin hydrochloride
    • Molecule of the month.
    • Molecule of the month. Dimebolin hydrochloride. Drug News Perspect 2007;20:467.
    • (2007) Drug News Perspect , vol.20 , pp. 467
  • 2
    • 47149116336 scopus 로고    scopus 로고
    • Dimebon in Alzheimer's disease: Old drug for new indication
    • Burns A, Jacoby R. Dimebon in Alzheimer's disease: Old drug for new indication. Lancet 2008;372:179-180.
    • (2008) Lancet , vol.372 , pp. 179-180
    • Burns, A.1    Jacoby, R.2
  • 3
    • 47149108940 scopus 로고    scopus 로고
    • Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study
    • Doody RS, Gavrilova SI, Sano M, et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study. Lancet 2008;372:207-215.
    • (2008) Lancet , vol.372 , pp. 207-215
    • Doody, R.S.1    Gavrilova, S.I.2    Sano, M.3
  • 4
    • 61849157257 scopus 로고    scopus 로고
    • Alzheimer's disease
    • Burns A, Iliffe S. Alzheimer's disease. BMJ 2009;338:179-180.
    • (2009) BMJ , vol.338 , pp. 179-180
    • Burns, A.1    Iliffe, S.2
  • 5
    • 79955707221 scopus 로고    scopus 로고
    • Alzheimer's Society 2007, Dementia UK report, London [Accessed March 30, 2010.
    • Alzheimer's Society 2007, Dementia UK report, London 2007. [Accessed March 30, 2010.
    • (2007)
  • 6
    • 75149173859 scopus 로고    scopus 로고
    • Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study
    • Brayne C, Richardson K, Matthews FE, et al. Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study. J Alzheimers Dis 2009;18:645-658.
    • (2009) J Alzheimers Dis , vol.18 , pp. 645-658
    • Brayne, C.1    Richardson, K.2    Matthews, F.E.3
  • 7
    • 33644942362 scopus 로고    scopus 로고
    • Quantification of Alzheimer pathology in ageing and dementia: Age-related accumulation of amyloid-beta(42) peptide in vascular dementia
    • Lewis H, Beher D, Cookson N, et al. Quantification of Alzheimer pathology in ageing and dementia: Age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol 2006;32:103-118.
    • (2006) Neuropathol Appl Neurobiol , vol.32 , pp. 103-118
    • Lewis, H.1    Beher, D.2    Cookson, N.3
  • 9
    • 33646184840 scopus 로고    scopus 로고
    • The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies
    • Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2006;111:115-125.
    • (2006) Acta Neuropathol , vol.111 , pp. 115-125
    • Sahin, H.A.1    Emre, M.2    Ziabreva, I.3    Perry, E.4    Celasun, B.5    Perry, R.6
  • 10
    • 0028873975 scopus 로고
    • Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
    • Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. J Neurochem 1995;64:749-760.
    • (1995) J Neurochem , vol.64 , pp. 749-760
    • Bierer, L.M.1    Haroutunian, V.2    Gabriel, S.3
  • 12
    • 79955722868 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence
    • Technology appraisals TA111. London NICE. 2007. [Accessed March 30, 2010.
    • National Institute for Health and Clinical Excellence 2007, Alzheimer's disease-donepezil, galantamine, rivastigmine (review) and memantine. Technology appraisals TA111. London NICE. 2007. [Accessed March 30, 2010.
    • (2007) Alzheimer's disease-donepezil, galantamine, rivastigmine (review) and memantine
  • 13
    • 41049111771 scopus 로고    scopus 로고
    • Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline
    • Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379-397.
    • (2008) Ann Intern Med , vol.148 , pp. 379-397
    • Raina, P.1    Santaguida, P.2    Ismaila, A.3
  • 14
    • 4344665066 scopus 로고    scopus 로고
    • Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: A review based on meta-analyses by the cochrane collaboration
    • Kurz A, Van Baelen B. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: A review based on meta-analyses by the cochrane collaboration. Dement Geriatr Cogn Disord 2004;18:217-226.
    • (2004) Dement Geriatr Cogn Disord , vol.18 , pp. 217-226
    • Kurz, A.1    Van Baelen, B.2
  • 15
    • 0036163534 scopus 로고    scopus 로고
    • The effect of selegiline in the treatment of people with Alzheimer's disease: A meta-analysis of published trials
    • Wilcock GK, Birks J, Whitehead A, Evans SJ. The effect of selegiline in the treatment of people with Alzheimer's disease: A meta-analysis of published trials. Int J Geriatr Psychiatry 2002;17:175-183.
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 175-183
    • Wilcock, G.K.1    Birks, J.2    Whitehead, A.3    Evans, S.J.4
  • 16
    • 0141483376 scopus 로고    scopus 로고
    • Current treatment for Alzheimer disease and future prospects
    • Tariot PN, Federoff HJ. Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord 2003;17(Suppl 4):S105-S113.
    • (2003) Alzheimer Dis Assoc Disord , vol.17 , Issue.SUPPL. 4
    • Tariot, P.N.1    Federoff, H.J.2
  • 17
    • 0030967165 scopus 로고    scopus 로고
    • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease Cooperative Study
    • Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease Cooperative Study. N Engl J Med 1997;336:1216-1222.
    • (1997) N Engl J Med , vol.336 , pp. 1216-1222
    • Sano, M.1    Ernesto, C.2    Thomas, R.G.3
  • 18
    • 0020643057 scopus 로고
    • Action of dimebon on histamine receptors
    • Matveeva IA. Action of dimebon on histamine receptors. Farmakol Toksikol 1983;46:27-29.
    • (1983) Farmakol Toksikol , vol.46 , pp. 27-29
    • Matveeva, I.A.1
  • 21
    • 0034944798 scopus 로고    scopus 로고
    • Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer
    • Bachurin S, Bukatina E, Lermontova N, et al. Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann N Y Acad Sci 2001;939:425-435.
    • (2001) Ann N Y Acad Sci , vol.939 , pp. 425-435
    • Bachurin, S.1    Bukatina, E.2    Lermontova, N.3
  • 24
    • 3242887701 scopus 로고    scopus 로고
    • Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
    • Grigorev VV, Dranyi OA, Bachurin SO. Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med 2003;136:474-477.
    • (2003) Bull Exp Biol Med , vol.136 , pp. 474-477
    • Grigorev, V.V.1    Dranyi, O.A.2    Bachurin, S.O.3
  • 25
    • 55349083365 scopus 로고    scopus 로고
    • Evaluation of Dimebon in cellular model of Huntington's disease
    • Wu J, Li Q, Bezprozvanny I. Evaluation of Dimebon in cellular model of Huntington's disease. Mol Neurodegener 2008;3:15, doi:.
    • (2008) Mol Neurodegener , vol.3 , pp. 15
    • Wu, J.1    Li, Q.2    Bezprozvanny, I.3
  • 26
    • 69349100072 scopus 로고    scopus 로고
    • Dimebolin is a 5-HT(6) antagonist with acute cognition enhancing activities
    • Schaffhauser H, Mathiasen JR, Dicamillo A, et al. Dimebolin is a 5-HT(6) antagonist with acute cognition enhancing activities. Biochem Pharmacol 2009;78:1035-1042.
    • (2009) Biochem Pharmacol , vol.78 , pp. 1035-1042
    • Schaffhauser, H.1    Mathiasen, J.R.2    Dicamillo, A.3
  • 27
    • 65749088098 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists
    • Ivachtchenko AV, Frolov EB, Mitkin OD, et al. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists. Bioorg Med Chem Lett 2009;19:3183-3187.
    • (2009) Bioorg Med Chem Lett , vol.19 , pp. 3183-3187
    • Ivachtchenko, A.V.1    Frolov, E.B.2    Mitkin, O.D.3
  • 29
    • 67650140610 scopus 로고    scopus 로고
    • Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
    • Yamashita M, Nonaka T, Arai T, et al. Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett 2009;583:2419-2424.
    • (2009) FEBS Lett , vol.583 , pp. 2419-2424
    • Yamashita, M.1    Nonaka, T.2    Arai, T.3
  • 30
    • 79955716997 scopus 로고    scopus 로고
    • ICAD Submitted Abstract #P1-254. A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil. Poster Session. July 12, 2009: 12:30-3:00 p.m. P Tariot - Presenter. 2009 International Conference on Alzheimer's Disease (ICAD), Vienna, Austria July
    • ICAD Submitted Abstract #P1-254. A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil. Poster Session. July 12, 2009: 12:30-3:00 p.m. P Tariot - Presenter. 2009 International Conference on Alzheimer's Disease (ICAD), Vienna, Austria July 2009;11-160.
    • (2009) , pp. 11-160
  • 31
    • 0021520020 scopus 로고
    • A new rating scale for Alzheimer's disease
    • Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
    • (1984) Am J Psychiatry , vol.141 , pp. 1356-1364
    • Rosen, W.G.1    Mohs, R.C.2    Davis, K.L.3
  • 33
    • 76249083708 scopus 로고    scopus 로고
    • Acute dosing of latrepirdine (DimebonTM), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo
    • Steele JW, Kim SH, Cirrito JR, et al. Acute dosing of latrepirdine (DimebonTM), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Mol Neurodegener 2009;4:51.
    • (2009) Mol Neurodegener , vol.4 , pp. 51
    • Steele, J.W.1    Kim, S.H.2    Cirrito, J.R.3
  • 35
    • 34249654120 scopus 로고    scopus 로고
    • Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine
    • Roegge CS, Perraut C, Hao X, Levin ED. Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav 2007;86:686-692.
    • (2007) Pharmacol Biochem Behav , vol.86 , pp. 686-692
    • Roegge, C.S.1    Perraut, C.2    Hao, X.3    Levin, E.D.4
  • 36
    • 34249943972 scopus 로고    scopus 로고
    • Role of hippocampal H1 receptors in radial maze performance and hippocampal theta activity in rats
    • Masuoka T, Kamei C. Role of hippocampal H1 receptors in radial maze performance and hippocampal theta activity in rats. Brain Res Bull 2007;73:231-237.
    • (2007) Brain Res Bull , vol.73 , pp. 231-237
    • Masuoka, T.1    Kamei, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.